NEW YORK (GenomeWeb news) – Luminex reported after the close of the market Thursday that its second-quarter 2009 revenues increased 14 percent, and it turned a net loss into a profit when compared with the same period in 2008.

The Austin, Texas-based molecular diagnostics instrumentation and assay maker had revenues of $27.8 million for the three-month period ended June 30, compared to revenues of $24.3 million for the second quarter last year. Analysts, on average, had expected revenues of $29.9 million for Q2 2009.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.

In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.

Genetic disease risk information doesn't always spur people to make healthy lifestyle changes, according to the Associated Press.

A University of California, San Diego-led team has used liquid biopsies to uncover possible treatments for patients with cancers of unknown primary.